Arkolith/Insider Trading/EPIX/Form 4

Virsik Peter

Chief Operating OfficerESSA Pharma Inc. (EPIX) · full profile →Form 4 · filed Jan 17, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$17K
Net Open-Market Flow
-$17K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 16, 2024Option exercise(M)2K$3.23$6K16K
Jan 16, 2024Sell(S)2K$10.01$17K14K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 16, 2024Option exercise(M)2K—$0968K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-24-001815) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML